Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
10 aug 2015 - 08:04
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug to present at Canaccord Genuity 35th Annual Growth Conference in Boston
Bericht
HALLE/SAALE, Germany, 10 August 2015 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease, announces that Dr Konrad Glund, CEO of Probiodrug, is scheduled to present at the Canaccord Genuity 35th Annual Growth Conference. The conference is being held in Boston, MA, at the InterContinental from the 12th to the 13th August 2015.
Datum laatste update: 08 februari 2025